Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleTNF-α inhibitor tanfanercept (HBM9036) improves signs and symptoms of dry eye in a phase 2 trial in the controlled adverse environment in China.AuthorsDong, Yanling; Wang, Shuang; Cong, Lin; Zhang, Ting; Cheng, Jun; Yang, Nannan; Qu, Xiaohong; Li, Dongfang; Zhou, Xueying; Wang, Holly; Lee, Michael; Wang, Meng; Chen, Stephen; Ousler, George W.; Chen, Xiaoxiang; Xie, LixinPublicationInternational Ophthalmology, 2022, Vol 42, Issue 8, p2459ISSN0165-5701Publication typeArticleDOI10.1007/s10792-022-02245-1